Valmark Advisers Inc. Grows Stake in Oracle Corporation $ORCL

Valmark Advisers Inc. grew its holdings in Oracle Corporation (NYSE:ORCL) by 32.8% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 8,199 shares of the enterprise software provider’s stock after acquiring an additional 2,026 shares during the quarter. Valmark Advisers Inc.’s holdings in Oracle were worth $1,792,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Nuveen LLC purchased a new position in Oracle during the 1st quarter worth approximately $732,692,000. Vanguard Group Inc. grew its stake in Oracle by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock worth $22,498,982,000 after buying an additional 3,513,464 shares during the last quarter. Kingstone Capital Partners Texas LLC purchased a new position in Oracle during the 2nd quarter worth approximately $731,512,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in Oracle by 79.2% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider’s stock worth $648,572,000 after buying an additional 2,049,687 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its stake in Oracle by 840.7% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider’s stock worth $463,380,000 after buying an additional 1,894,157 shares during the last quarter. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Oracle Stock Up 1.5%

ORCL opened at $288.48 on Thursday. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. The business has a 50 day simple moving average of $264.86 and a 200-day simple moving average of $207.92. The stock has a market capitalization of $822.40 billion, a P/E ratio of 66.78, a P/E/G ratio of 3.06 and a beta of 1.53. Oracle Corporation has a 12 month low of $118.86 and a 12 month high of $345.72.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.48 by ($0.01). The firm had revenue of $14.93 billion for the quarter, compared to analyst estimates of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, equities analysts anticipate that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 annualized dividend and a yield of 0.7%. Oracle’s payout ratio is currently 46.30%.

Analyst Upgrades and Downgrades

ORCL has been the subject of a number of recent research reports. TD Cowen increased their price objective on Oracle from $325.00 to $375.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Royal Bank Of Canada increased their price objective on Oracle from $145.00 to $195.00 and gave the stock a “sector perform” rating in a research report on Thursday, June 12th. Oppenheimer reaffirmed an “outperform” rating on shares of Oracle in a research report on Wednesday, June 18th. KeyCorp increased their price objective on Oracle from $200.00 to $225.00 and gave the stock an “overweight” rating in a research report on Thursday, June 12th. Finally, Melius Research increased their price objective on Oracle from $270.00 to $370.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Two research analysts have rated the stock with a Strong Buy rating, twenty-six have given a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $306.43.

Insider Transactions at Oracle

In related news, insider Michael D. Sicilia sold 33,845 shares of Oracle stock in a transaction on Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the transaction, the insider directly owned 132,656 shares of the company’s stock, valued at approximately $42,603,800.96. The trade was a 20.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director William G. Parrett sold 11,500 shares of Oracle stock in a transaction on Friday, September 12th. The stock was sold at an average price of $306.00, for a total value of $3,519,000.00. Following the transaction, the director directly owned 17,764 shares of the company’s stock, valued at approximately $5,435,784. This represents a 39.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 104,314 shares of company stock valued at $31,272,223. Company insiders own 40.90% of the company’s stock.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.